Zurich Cantonal Bank
SKYE icon

Zurich Cantonal Bank’s Skye Bioscience SKYE Stock Holding History

Zurich Cantonal Bank’s Portfolio SKYE Stock Details SKYE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$36 Hold
7
– – ﹤0.01% 2536
2026
Q1 		$32 Hold
7
– – ﹤0.01% 2533
2025
Q4 		$39 Sell
7
-3,651
-100% -$42.7K ﹤0.01% 2527
2025
Q3 		$115K Sell
3,658
-323
-8% -$9.76K ﹤0.01% 2358
2025
Q2 		$133K Buy
3,981
+1,246
+46% +$20.6K ﹤0.01% 2303
2025
Q1 		$34.8K Buy
2,735
+40
+1% +$874 ﹤0.01% 2543
2024
Q4 		$61K Buy
+2,695
New +$90.1K ﹤0.01% 2539

Other funds holding SKYE

5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Zurich Cantonal Bank's SKYE Position: Q2 2026 in Review

Zurich Cantonal Bank held its Skye Bioscience (SKYE) position steady in Q2 2026 at 7 shares worth $36. The position accounts for ﹤0.01% of the portfolio, ranked #2536.

Zurich Cantonal Bank first reported a position in SKYE in Q4 2024 and has held it in 7 quarters since. The position peaked at $133K in Q2 2025. 33 funds tracked by Wall St. Rank hold SKYE as of Q2 2026.

  • Zurich Cantonal Bank held 7 shares of Skye Bioscience worth $36 as of Q2 2026.
  • Zurich Cantonal Bank left its Skye Bioscience share count unchanged in Q2 2026.
  • Skye Bioscience made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #2536 holding.
  • Zurich Cantonal Bank first reported a position in Skye Bioscience in Q4 2024 and has held it in 7 quarters since.
  • Zurich Cantonal Bank's Skye Bioscience position peaked at $133K in Q2 2025.
  • 33 funds tracked by Wall St. Rank held Skye Bioscience as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.